UltraCare: will it give FMC (Fresenius Medical Care) the edge over Gambro in US?
This article was originally published in Clinica
Executive Summary
Gambro needs to decide how to respond strategically to Fresenius Medical Care's new single-use dialyser treatment, UltraCare, in the US, according to a recent report by Alexander Burgansky, research analyst with Credit Suisse First Boston.